XPA and ovarian carcinoma: Enhanced NER gene expression is a major cause of resistance to cisplatin and other DNA-damaging chemotherapeutic agents [3,28] and over expression of the XPA gene component of NER has been associated with resistance to cisplatin in human ovarian cancer [4,24].